{"id":"W2621872277","doi":"10.1016/j.ejca.2017.05.003","title":"Corrigendum to ‘Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer’ [European Journal of Cancer 76 (2017) 36–44]","year":2017,"lang":"en","type":"erratum","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Abiraterone acetate; Prostate cancer; Medicine; PI3K/AKT/mTOR pathway; PTEN; Internal medicine; Androgen receptor; Cancer research; Oncology; Cancer; Chemistry; Androgen deprivation therapy; Apoptosis; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002423671,0.0009928655,0.002527267,0.00142143,0.0003334742,0.0003079606,0.001328626,0.0001237959,0.0004919045],"category_scores_gemma":[0.0002161213,0.0006287706,0.000337811,0.000656259,0.0003074197,0.0006620789,0.0002578683,0.002620366,0.00001017285],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002137112,"about_ca_system_score_gemma":0.006346398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001426506,"about_ca_topic_score_gemma":0.006042127,"domain_scores_codex":[0.991086,0.001242694,0.003062396,0.000732567,0.002784808,0.001091551],"domain_scores_gemma":[0.9883639,0.0000509548,0.006265573,0.0009265218,0.003423077,0.0009700122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.2190987,0.006073974,0.08879803,0.002538761,0.008566614,0.04350285,0.03312575,0.002517663,0.003466554,0.000001073324,0.4676954,0.1246147],"study_design_scores_gemma":[0.1149431,0.04258655,0.6714743,0.02379603,0.003200292,0.0001962561,0.003136957,0.00003409773,0.0008782268,0.000001698999,0.1383719,0.001380603],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9634544,0.01363367,0.00001362776,0.0007557154,0.01567674,0.002741008,0.0009404891,0.00001702543,0.00276727],"genre_scores_gemma":[0.9249758,0.01047247,0.0001340458,0.0001314316,0.003563631,0.00003788659,0.00008806085,0.0004058881,0.06019077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5826763,"threshold_uncertainty_score":0.9996806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08206746764147864,"score_gpt":0.3813537497478732,"score_spread":0.2992862821063945,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}